Edition:
United Kingdom

Agenus Inc (AGEN.OQ)

AGEN.OQ on NASDAQ Stock Exchange Capital Market

1.96USD
4:51pm BST
Change (% chg)

$0.05 (+2.62%)
Prev Close
$1.91
Open
$1.92
Day's High
$1.99
Day's Low
$1.89
Volume
76,031
Avg. Vol
291,392
52-wk High
$6.19
52-wk Low
$1.56

Chart for

About

Agenus Inc. (Agenus) is an immuno-oncology (I-O) company. The Company focuses on the discovery and development of therapies that engage the body's immune system to fight cancer. It is developing a I-O portfolio driven by platforms and programs, such as antibody discovery platforms, including Retrocyte Display, SECANT yeast... (more)

Overall

Beta: 2.17
Market Cap(Mil.): $409.77
Shares Outstanding(Mil.): 87.00
Dividend: --
Yield (%): --

Financials

  AGEN.OQ Industry Sector
P/E (TTM): -- 85.68 32.76
EPS (TTM): -1.27 -- --
ROI: -75.39 1.78 14.61
ROE: -- 3.29 16.33

BRIEF-Agenus Inc Says Terminated Controlled Equity Offering Sales Agreement With Cantor Fitzgerald & Co

* AGENUS INC - ON MAY 7 TERMINATED CONTROLLED EQUITY OFFERING(SM)SALES AGREEMENT WITH CANTOR FITZGERALD & CO

08 May 2018

BRIEF-Agenus Q1 Loss Per Share $0.53

* AGENUS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

07 May 2018

Earnings vs. Estimates